Sangamo Therapeutics, Inc (SGMO): 8-K filed Jul 1, 2026

Form type

8-K

Filing date

Jul 1, 2026

Accession number

0001193125-26-292501

Filer

Sangamo Therapeutics, Inc (CIK 1001233)